Breaking News Instant updates and real-time market news.

2020-11-25 14:16:07 $NYE NYSE Market Internals $0.00 / + (+0.00%) 14:16 11/25/20 11/25 14:16 11/25/20 14:16	NYSE market internals summary Volume is above average for this time of day. Breadth is mixed with issues and volume bearish while new highs to new lows are bullish (positive divergence). Advancing Issues: 1343 / Declining Issues: 1733 -- for a ratio of 0.8 to 1. Advancing Volume: 1,511,148,000 / Declining Volume: 1,615,297,000 -- for a ratio of 0.9 to 1. New 52-Week Highs: 273 / New 52-Week Lows: 6.

2020-11-25 14:16:07

$NYE

NYSE Market Internals

$0.00 / + (+0.00%)

14:16

11/25/20

11/25

14:16

11/25/20

14:16

NYSE market internals summary

Volume is above average for this time of day. Breadth is mixed with issues and volume bearish while new highs to new lows are bullish (positive divergence). Advancing Issues: 1343 / Declining Issues: 1733 -- for a ratio of 0.8 to 1. Advancing Volume: 1,511,148,000 / Declining Volume: 1,615,297,000 -- for a ratio of 0.9 to 1. New 52-Week Highs: 273 / New 52-Week Lows: 6.

TODAY'S FREE FLY STORIES

Earnings	Plumas Bancorp reports Q4 EPS 82c vs. 74c last year » 09:07 01/20/21 01/20 09:07 01/20/21 09:07 PLBC Plumas Bancorp $24.57 / -0.4 (-1.60%) Total assets increased by… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings PLBC Plumas Bancorp $24.57 / -0.4 (-1.60%) 10/21/20 Plumas Bancorp reports Q4 EPS 71c vs. 78c last year
Earnings	First Community reports Q4 EPS 46c, consensus 34c » 09:07 01/20/21 01/20 09:07 01/20/21 09:07 FCCO First Community $17.43 / + (+0.00%) Reports Q4 NII $10.7M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings FCCO First Community $17.43 / + (+0.00%) 10/19/20 Stephens First Community resumed with an Equal Weight at Stephens 07/27/20 Raymond James First Community upgraded to Outperform from Market Perform at Raymond James 07/27/20 Raymond James First Community initiated with an Outperform at Raymond James 06/09/20 DA Davidson First Community upgraded to Buy from Neutral at DA Davidson FCCO First Community $17.43 / + (+0.00%) 10/21/20 First Community reports Q3 EPS 35c, consensus 31c 07/22/20 First Community reports Q2 EPS 30c, consensus 21c
Recommendations	Repligen price target raised to $245 from $229 at Craig-Hallum » 09:07 01/20/21 01/20 09:07 01/20/21 09:07 RGEN Repligen $222.27 / +6.82 (+3.17%) Craig-Hallum analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate RGEN Repligen $222.27 / +6.82 (+3.17%) 10/27/20 Repligen to acquire ARTeSYN Biosolutions for $200M in cash, stock 10/01/20 Repligen and Navigo Proteins achieve milestone in COVID-19 vaccine resin RGEN Repligen $222.27 / +6.82 (+3.17%) 11/09/20 KeyBanc Repligen initiated with an Overweight at KeyBanc 08/24/20 H.C. Wainwright Repligen price target raised to $168 from $151 at H.C. Wainwright 06/30/20 H.C. Wainwright Repligen price target raised to $151 from $143 at H.C. Wainwright 05/27/20 Stifel Repligen price target raised to $150 from $135 at Stifel RGEN Repligen $222.27 / +6.82 (+3.17%) 11/05/20 Repligen sees FY20 adj. EPS $1.41-$1.45, consensus $1.28 11/05/20 Repligen reports Q3 adj. EPS 40c, consensus 28c 07/30/20 Repligen sees FY20 adj. EPS $1.24-$1.29, consensus $1.13 07/30/20 Repligen reports Q2 adj. EPS 42c, consensus 27c 08 Dec
Recommendations	DermTech price target raised to $49 from $23 at Craig-Hallum » 09:06 01/20/21 01/20 09:06 01/20/21 09:06 DMTK DermTech $40.47 / +1.53 (+3.93%) Craig-Hallum analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DMTK DermTech $40.47 / +1.53 (+3.93%) 01/14/21 DermTech announces PLA study results published 01/12/21 DermTech says genomic patch testing for melanoma recommended by NCCN 01/05/21 DermTech appoints Ray Akhavan as general counsel 12/29/20 DermTech gets positive medical coverage by Geisinger Health System DMTK DermTech $40.47 / +1.53 (+3.93%) 01/12/21 Lake Street DermTech price target raised to $52 from $24 at Lake Street 12/14/20 Craig-Hallum Craig-Hallum bullish on DermTech, initiates with a Buy 12/14/20 Craig-Hallum DermTech initiated with a Buy at Craig-Hallum 10/29/20 William Blair DermTech initiated with an Outperform at William Blair DMTK DermTech $40.47 / +1.53 (+3.93%) 11/10/20 DermTech reports Q3 EPS (50c), consensus (55c) 07 Jan DMTK DermTech $40.47 / +1.53 (+3.93%) 01/12/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Wall Street's top stories for Wednesday DMTK DermTech $40.47 / +1.53 (+3.93%) 11/25/20 new option listings on November 25th
Recommendations	Netflix price target raised to $700 from $650 at Morgan Stanley » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 NFLX Netflix / + Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix / + 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix / + 09:00 Today Wedbush Netflix price target raised to $340 from $235 at Wedbush 08:47 Today Credit Suisse Netflix price target raised to $586 from $525 at Credit Suisse 08:05 Today Jefferies Netflix price target raised to $650 from $610 at Jefferies 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays NFLX Netflix / + 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix / + 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix / + 08:59 Today Fly Intel: Pre-market Movers 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions NFLX Netflix / + 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st

Hot Stocks	Cadence to acquire NUMECA to expand system analysis capabilities » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 CDNS Cadence Design $137.60 / +2.94 (+2.18%) Cadence Design Systems… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CDNS Cadence Design $137.60 / +2.94 (+2.18%) 12/08/20 Samsung Foundry adopts Cadence Spectre X Simulator for 5nm design 11/05/20 Cadence Design opens new R&D center in Ireland to expand software development 08/12/20 Cadence announces enhancement of Xcelium Logic Simulator with ML technology CDNS Cadence Design $137.60 / +2.94 (+2.18%) 01/11/21 BofA Cadence Design downgraded to Underperform from Buy at BofA 01/05/21 KeyBanc Cadence Design upgraded to Overweight at KeyBanc 01/04/21 KeyBanc Cadence Design upgraded to Overweight from Sector Weight at KeyBanc 12/09/20 Fly Intel: Top five analyst upgrades CDNS Cadence Design $137.60 / +2.94 (+2.18%) 10/19/20 Cadence Design raises FY20 adj. EPS view to $2.68-$2.72 from $2.50-$2.56 10/19/20 Cadence Design sees Q4 adjusted EPS 72c-76c, consensus 68c 10/19/20 Cadence Design reports Q3 adjusted EPS 70c, consensus 61c 10/19/20 Notable companies reporting after market close CDNS Cadence Design $137.60 / +2.94 (+2.18%) 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 07/20/20 Fly Intel: After-Hours Movers 02/22/21 Cadence Design - CDNS CDNS Cadence Design $137.60 / +2.94 (+2.18%) 07/20/20 Cadence Design options imply 8.5% move in share price post-earnings
Recommendations	Proto Labs price target raised to $167 from $105 at Craig-Hallum » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 PRLB Proto Labs $179.83 / +11.2 (+6.64%) Craig-Hallum analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PRLB Proto Labs $179.83 / +11.2 (+6.64%) 01/19/21 Proto Labs acquires 3D Hubs for $280M 12/14/20 Proto Labs announces Robert Bodor to succeed Vicki Holt as CEO PRLB Proto Labs $179.83 / +11.2 (+6.64%) 10/20/20 Northcoast Prototyping business survey shows COVID ongoing drag, says Northcoast 10/09/20 Berenberg Proto Labs assumed with a Hold at Berenberg 05/14/20 Benchmark Benchmark starts Proto Labs at Buy, sees COVID-19 programs filling order gap 05/14/20 Benchmark Proto Labs initiated with a Buy at Benchmark PRLB Proto Labs $179.83 / +11.2 (+6.64%) 10/29/20 Proto Labs sees Q4 revenue $96M-$106M, consensus $107.3M 10/29/20 Proto Labs reports Q3 non-GAAP EPS 67c, consensus 52c 07/28/20 Proto Labs sees Q3 revenue $98M-$110M, consensus $103.95M 07/28/20 Proto Labs reports Q2non-GAAP EPS 59c, consensus 36c
Hot Stocks	U.S. Bancorp continues to target flat sequential expense levels 09:04 01/20/21 01/20 09:04 01/20/21 09:04 USB U.S. Bancorp $48.05 / -0.39 (-0.81%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 09:04 Today U.S. Bancorp: Payment volume trends to continue to improve 06:49 Today U.S. Bancorp reports Q4 CET1 capital ratio 9.7% vs. 9.1% a year ago 06:48 Today U.S. Bancorp reports Q4 net interest margin 2.57% vs. 2.92% a year ago 06:47 Today U.S. Bancorp reports Q4 return on average assets of 1.10% USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/07/21 Jefferies U.S. Bancorp upgraded to Buy with $58 price target at Jefferies 01/07/21 BofA U.S. Bancorp downgraded to Underperform from Neutral at BofA 01/07/21 Jefferies U.S. Bancorp upgraded to Buy from Hold at Jefferies 01/06/21 Deutsche Bank U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 06:46 Today U.S. Bancorp reports Q4 EPS 95c, consensus 95c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/14/20 U.S. Bancorp reports Q3 diluted EPS 99c, consensus 91c USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 11/25/20 Bank of America rumors of flat bonus pool rattles traders, Bloomberg says 09/29/20 Citi's McGuire meets with banking leaders over likely NYC mayoral run, CNBC says 09/17/20 Fed mulls extension of bank dividend restrictions, Bloomberg says USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 08:59 Today Fly Intel: Pre-market Movers 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/14/20 Fly Intel: Pre-market Movers 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today U.S. Bancorp - USB 01/25/21 U.S. Bancorp USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/04/21 US Bancorp put volume heavy and directionally bearish 12/02/20 US Bancorp put volume heavy and directionally bearish 09/14/20 US Bancorp call volume above normal and directionally bullish
Hot Stocks	Adamis Pharmaceuticals submits Tempol IND application to FDA » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 ADMP Adamis Pharmaceuticals $0.81 / +0.0321 (+4.15%) Adamis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Options ADMP Adamis Pharmaceuticals $0.81 / +0.0321 (+4.15%) 12/01/20 Adamis Pharmaceuticals intends to address all deficiencies in ZIMHI CRL 11/16/20 Adamis plunges after Complete Response Letter from FDA for ZIMHI application 08/25/20 Adamis Pharmaceuticals provides update on Annual Meeting of Stockholders 08/21/20 Adamis Pharmaceuticals provides update on Annual Meeting of Stockholders ADMP Adamis Pharmaceuticals $0.81 / +0.0321 (+4.15%) 11/17/20 Adamis Pharmaceuticals cut to Hold at Maxim after Zimhi CRL from FDA 11/16/20 Maxim Adamis Pharmaceuticals downgraded to Hold from Buy at Maxim 05/13/20 Maxim Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim 05/13/20 Maxim Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim 18 Sep ADMP Adamis Pharmaceuticals $0.81 / +0.0321 (+4.15%) 08/28/20 Largest borrow rate increases among liquid names 08/26/20 Largest borrow rate increases among liquid names 08/14/20 Largest borrow rate increases among liquid names 07/30/20 Unusual call flow in option market yesterday
Hot Stocks	U.S. Bancorp: Payment volume trends to continue to improve » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 USB U.S. Bancorp $48.05 / -0.39 (-0.81%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 06:49 Today U.S. Bancorp reports Q4 CET1 capital ratio 9.7% vs. 9.1% a year ago 06:48 Today U.S. Bancorp reports Q4 net interest margin 2.57% vs. 2.92% a year ago 06:47 Today U.S. Bancorp reports Q4 return on average assets of 1.10% 01/06/21 U.S. Bank acquires client portfolio from MUFG Union Bank USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/07/21 Jefferies U.S. Bancorp upgraded to Buy with $58 price target at Jefferies 01/07/21 BofA U.S. Bancorp downgraded to Underperform from Neutral at BofA 01/07/21 Jefferies U.S. Bancorp upgraded to Buy from Hold at Jefferies 01/06/21 Deutsche Bank U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 06:46 Today U.S. Bancorp reports Q4 EPS 95c, consensus 95c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/14/20 U.S. Bancorp reports Q3 diluted EPS 99c, consensus 91c USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 11/25/20 Bank of America rumors of flat bonus pool rattles traders, Bloomberg says 09/29/20 Citi's McGuire meets with banking leaders over likely NYC mayoral run, CNBC says 09/17/20 Fed mulls extension of bank dividend restrictions, Bloomberg says USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 08:59 Today Fly Intel: Pre-market Movers 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/14/20 Fly Intel: Pre-market Movers 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today U.S. Bancorp - USB 01/25/21 U.S. Bancorp USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/04/21 US Bancorp put volume heavy and directionally bearish 12/02/20 US Bancorp put volume heavy and directionally bearish 09/14/20 US Bancorp call volume above normal and directionally bullish

Hot Stocks	Werner announces equity investment in TuSimple » 09:04 01/20/21 01/20 09:04 01/20/21 09:04 WERN Werner $42.25 / +0.3 (+0.72%) Werner Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events WERN Werner $42.25 / +0.3 (+0.72%) 09/16/20 Werner, Platform Science announce technology partnership WERN Werner $42.25 / +0.3 (+0.72%) 01/19/21 Credit Suisse Werner upgraded to Neutral from Underperform at Credit Suisse 12/14/20 Wells Fargo Werner downgraded to Underweight from Equal Weight at Wells Fargo 12/04/20 Evercore starts trucking coverage with preference for Old Dominion, Saia 12/04/20 Evercore ISI Werner initiated with an In Line at Evercore ISI WERN Werner $42.25 / +0.3 (+0.72%) 10/28/20 Werner reports Q3 EPS 69c, consensus 66c 07/29/20 Werner reports Q2 adj. EPS 62c, consensus 40c 07/29/20 Notable companies reporting after market close 04 Jun WERN Werner $42.25 / +0.3 (+0.72%) 10/28/20 Fly Intel: After-Hours Movers 02/04/21 Werner - WERN
Recommendations	Kulicke & Soffa price target raised to $55 from $40 at Craig-Hallum » 09:03 01/20/21 01/20 09:03 01/20/21 09:03 KLIC Kulicke & Soffa $38.64 / +0.55 (+1.44%) Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events KLIC Kulicke & Soffa $38.64 / +0.55 (+1.44%) 12/10/20 Kulicke & Soffa raises quarterly dividend 16.7% to 14c per share 09/21/20 Kulicke & Soffa announces orders of 1,500 RAPID series system 09/15/20 Kulicke & Soffa names Peter Kong next chairman of the board KLIC Kulicke & Soffa $38.64 / +0.55 (+1.44%) 12/14/20 B. Riley Securities Kulicke & Soffa price target raised to $44 from $38 at B. Riley Securities 11/20/20 DA Davidson Kulicke & Soffa price target raised to $40 from $33 at DA Davidson 11/20/20 B. Riley Securities Kulicke & Soffa price target raised to $38 from $36 at B. Riley Securities 11/09/20 B. Riley Securities Kulicke & Soffa price target raised to $36 from $31 at B. Riley Securities KLIC Kulicke & Soffa $38.64 / +0.55 (+1.44%) 01/19/21 Kulicke & Soffa raises Q1 non-GAAP EPS view to 73c-77c from 48c-58c 11/18/20 Kulicke & Soffa sees Q1 EPS 48c-58c, consensus 25c 11/18/20 Kulicke & Soffa reports Q4 EPS 29c, consensus 31c 10/13/20 Kulicke & Soffa raises Q4 revenue view to $177M from $165M 02/04/21 Kulicke & Soffa - KLIC
Hot Stocks	Infrastructure and Energy Alternatives awarded $45M construction contract » 09:03 01/20/21 01/20 09:03 01/20/21 09:03 IEA Infrastructure and Energy Alternatives $22.21 / +0.87 (+4.08%) Infrastructure and Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options IEA Infrastructure and Energy Alternatives $22.21 / +0.87 (+4.08%) 01/14/21 Silicon Ranch selects Infrastructure and Energy Alternatives for solar project 01/12/21 Infrastructure and Energy Alternatives secures $100M wind construction contract 12/29/20 Infrastructure and Energy Alternatives secures 185 MW wind construction contract 12/18/20 Infrastructure and Energy Alternatives to be added to NACEX IEA Infrastructure and Energy Alternatives $22.21 / +0.87 (+4.08%) 11/11/20 DA Davidson Infrastructure and Energy Alternatives price target raised to $13 at DA Davidson 06/11/20 DA Davidson Infrastructure and Energy Alternatives upgraded to Buy from Neutral at DA Davidson 06/11/20 DA Davidson Infrastructure and Energy Alternatives upgraded to Buy at DA Davidson IEA Infrastructure and Energy Alternatives $22.21 / +0.87 (+4.08%) 11/03/20 Fly Intel: Pre-market Movers IEA Infrastructure and Energy Alternatives $22.21 / +0.87 (+4.08%) 11/23/20 Seven new option listings and six option delistings on November 23rd
Hot Stocks	Arcutis to advance topical roflumilast foam into Phase 3 development » 09:03 01/20/21 01/20 09:03 01/20/21 09:03 ARQT Arcutis Biotherapeutics $28.69 / -0.19 (-0.66%) Arcutis Biotherapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ARQT Arcutis Biotherapeutics $28.69 / -0.19 (-0.66%) 01/13/21 Arcutis initiaties Phase 3 clinical trials of topical roflumilast cream 01/11/21 Arcutis Biotherapeutics appoints Matthew Moore as CBO 12/21/20 Arcutis Biotherapeutics added to the Nasdaq Biotechnology Index 12/07/20 Arcutis says last patient completes final visit in DERMIS-1, DERMIS-2 trials ARQT Arcutis Biotherapeutics $28.69 / -0.19 (-0.66%) 11/09/20 Goldman Sachs Arcutis Biotherapeutics upgraded to Buy from Neutral at Goldman Sachs 10/08/20 Truist Arcutis Biotherapeutics initiated with a Buy at Truist 10/08/20 Truist Arcutis Biotherapeutics initiated with a Buy at Truist 03/20/20 Cantor Fitzgerald Arcutis dermatology potential remains underappreciated, says Cantor Fitzgerald ARQT Arcutis Biotherapeutics $28.69 / -0.19 (-0.66%) 11/05/20 Arcutis Biotherapeutics reports Q3 EPS ($1.01), consensus (90c) 08/11/20 Arcutis Biotherapeutics reports Q2 EPS (94c), consensus (84c) 02 Oct 31 Jan ARQT Arcutis Biotherapeutics $28.69 / -0.19 (-0.66%) 10/12/20 Fly Insider: Element Solutions, Sunrun among week's notable insider trades 09/29/20 Fly Intel: After-Hours Movers
Hot Stocks	Opera acquires YoYo Games for approximately $10M » 09:02 01/20/21 01/20 09:02 01/20/21 09:02 OPRA Opera $9.59 / +0.25 (+2.68%) Opera announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OPRA Opera $9.59 / +0.25 (+2.68%) 12/30/20 Opera PC users reach 80M MAUs 10/26/20 Opera reports monthly active user growth to 387M in September 09/02/20 Opera joins Emerging Payments Association EU 08/20/20 Opera forms Nanobank by combining microlending business, Mobimagic OPRA Opera $9.59 / +0.25 (+2.68%) 11/20/20 Lake Street Opera price target raised to $12 from $11 at Lake Street 08/24/20 Lake Street Opera price target lowered to $11 from $15 at Lake Street 08/03/20 Citi Opera price target raised to $12 from $8 at Citi 05/21/20 Lake Street Opera Q2 to be low point for COVID headwinds, says Lake Street OPRA Opera $9.59 / +0.25 (+2.68%) 01/11/21 Opera sees Q4 revenue at top-end of $45M-$47M, two est. $45.92M 11/19/20 Opera reports Q3 adj. EPS 8c, consensus 31c 11/19/20 Opera sees 2021 revenue $200M, consensus $199.5M 11/19/20 Opera sees Q4 revenue $45M-$47M, consensus $45.13M OPRA Opera $9.59 / +0.25 (+2.68%) 08/20/20 Fly Intel: Wall Street's top stories for Thursday 08/20/20 Fly Intel: Wall Street's top stories at midday 08/20/20 Fly Intel: Pre-market Movers

Hot Stocks	Textainer acquires 49.9% of TAP Funding » 09:02 01/20/21 01/20 09:02 01/20/21 09:02 TGH Textainer $19.86 / +0.42 (+2.16%) Textainer's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TGH Textainer $19.86 / +0.42 (+2.16%) 09/14/20 Textainer increases share buyback by $50M TGH Textainer $19.86 / +0.42 (+2.16%) 01/19/21 B. Riley Securities Triton, Textainer, CAI boosted by 'containergeddon,' says B. Riley Securities 12/09/20 B. Riley Securities B. Riley starts 'misunderstood' Textainer with Buy, $31 price target 12/09/20 B. Riley Securities Textainer initiated with a Buy at B. Riley Securities 10/19/20 Keefe Bruyette Textainer upgraded to Outperform from Market Perform at Keefe Bruyette
Downgrade	Canadian Pacific downgraded to Sector Perform from Outperform at Scotiabank » 09:01 01/20/21 01/20 09:01 01/20/21 09:01 CP Canadian Pacific / + Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CP Canadian Pacific / + 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 12/24/20 North American rail traffic rose 1.9% in week ended December 19 CP Canadian Pacific / + 01/19/21 CIBC Canadian Pacific price target raised to C$500 from C$490 at CIBC 01/11/21 Citi Canadian Pacific price target raised to $430 from $355 at Citi 12/17/20 National Bank Canadian Pacific price target raised to C$445 from C$433 at National Bank 12/07/20 CIBC Canadian Pacific price target raised to C$490 from C$444 at CIBC CP Canadian Pacific / + 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year 07/22/20 Canadian Pacific sees adjusted diluted EPS growth year over year 07/22/20 Canadian Pacific reports Q2 adjusted EPS C$4.07 vs. C$4.30 last year 01/27/21 Canadian Pacific - CP
Downgrade	Canadian National downgraded to Sector Perform from Outperform at Scotiabank » 09:01 01/20/21 01/20 09:01 01/20/21 09:01 CNI Canadian National $109.70 / -1.765 (-1.58%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CNI Canadian National $109.70 / -1.765 (-1.58%) 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 12/30/20 CN completes U.S. federal requirement to operate Positive Train Control CNI Canadian National $109.70 / -1.765 (-1.58%) 01/13/21 Barclays Canadian National upgraded to Equal Weight from Underweight at Barclays 01/11/21 Bernstein Canadian National upgraded to Outperform from Market Perform at Bernstein 01/11/21 Citi Canadian National price target raised to $127 from $110 at Citi 12/07/20 CIBC Canadian National price target raised to C$153 from C$141 at CIBC CNI Canadian National $109.70 / -1.765 (-1.58%) 10/20/20 Canadian National reports Q3 EPS $C$1.38 versus $C1.66 in Q319 07/21/20 Canadian National reports Q2 EPS C$1.28, consensus C$1.26 01/26/21 Canadian National - CNI
Recommendations	Netflix price target raised to $340 from $235 at Wedbush » 09:00 01/20/21 01/20 09:00 01/20/21 09:00 NFLX Netflix $501.85 / +3.9 (+0.78%) Wedbush analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 08:47 Today Credit Suisse Netflix price target raised to $586 from $525 at Credit Suisse 08:05 Today Jefferies Netflix price target raised to $650 from $610 at Jefferies 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 08:59 Today Fly Intel: Pre-market Movers 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
On The Fly	Fly Intel: Pre-market Movers » 08:59 01/20/21 01/20 08:59 01/20/21 08:59 PG Procter & Gamble $133.56 / -1.275 (-0.95%) , MS Morgan Stanley $74.99 / -0.23 (-0.31%) , NFLX Netflix $501.85 / +3.9 (+0.78%) , USB U.S. Bancorp $48.05 / -0.39 (-0.81%) , GEVO Gevo $11.01 / +4.62 (+72.30%) , CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) , CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) , APM Aptorum Group $3.17 / -0.11 (-3.35%) Check out this morning's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PG MS NFLX USB GEVO CRNT CTMX APM PG Procter & Gamble $133.56 / -1.275 (-0.95%) 08:49 Today Procter & Gamble says strong momentum continued in Q2 01/05/21 Procter & Gamble to terminate deal to buy Billie after FTC challenge 12/09/20 Procter & Gamble names Andre Schulten as CFO 12/08/20 FTC sues to block Procter & Gamble's acquisition of Billie, Inc. MS Morgan Stanley $74.99 / -0.23 (-0.31%) 08:56 Today Morgan Stanley expects net new assets to remain above historical levels 08:55 Today Morgan Stanley doesn't see any change to policy rates in the near-term 08:45 Today Morgan Stanley: LT goal is for wealth management to generate margin of over 30% 08:44 Today Morgan Stanley CEO: 2021 to be a transition year NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 06:49 Today U.S. Bancorp reports Q4 CET1 capital ratio 9.7% vs. 9.1% a year ago 06:48 Today U.S. Bancorp reports Q4 net interest margin 2.57% vs. 2.92% a year ago 06:47 Today U.S. Bancorp reports Q4 return on average assets of 1.10% 01/06/21 U.S. Bank acquires client portfolio from MUFG Union Bank GEVO Gevo $11.01 / +4.62 (+72.30%) 01/11/21 Gevo announces concept of Net-Zero Projects 01/06/21 Gevo pays off Whitebox Convertible Senior Secured Notes 01/04/21 Gevo engages Koch Project Solutions for expansion prokects 12/21/20 Gevo options site for expansion project CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 09/16/20 Ceragon Networks' new quad-carrier outdoor solution selected by 5G providers 08/03/20 Ceragon Networks selected by Orange Niger for 4G deployment support CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 01/19/21 CytomX Therapeutics announces $75M offering of common stock 01/19/21 CytomX Therapeutics announces employment inducement grants 11/05/20 CytomX Therapeutics treats first patient in Phase 2 expansion study of CX-2029 10/06/20 CytomX Therapeutics announces retirement of CSO Michael Kavanaugh APM Aptorum Group $3.17 / -0.11 (-3.35%) 06:02 Today Aptorum Group's Phase 1 ALS-4 trial receives clearance from Health Canada 12/21/20 Aptorum Group submits CTA to Health Canada to conduct Phase 1 trial of ALS-4 09/29/20 Aptorum Group launches infectious disease liquid biopsy subsidiary PG MS NFLX USB GEVO CRNT CTMX APM PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 12/07/20 Wells Fargo Colgate-Palmolive initiated with an Underweight at Wells Fargo MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/11/21 Piper Sandler Morgan Stanley price target raised to $76 from $54 at Piper Sandler 01/06/21 Deutsche Bank Morgan Stanley price target raised to $68 from $53 at Deutsche Bank 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Barclays Morgan Stanley upgraded to Overweight with $88 target at Barclays NFLX Netflix $501.85 / +3.9 (+0.78%) 08:47 Today Credit Suisse Netflix price target raised to $586 from $525 at Credit Suisse 08:05 Today Jefferies Netflix price target raised to $650 from $610 at Jefferies 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/07/21 Jefferies U.S. Bancorp upgraded to Buy with $58 price target at Jefferies 01/07/21 BofA U.S. Bancorp downgraded to Underperform from Neutral at BofA 01/07/21 Jefferies U.S. Bancorp upgraded to Buy from Hold at Jefferies 01/06/21 Deutsche Bank U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank GEVO Gevo $11.01 / +4.62 (+72.30%) 01/19/21 Noble Capital Gevo price target raised to $8.25 from $5 at Noble Capital 12/31/20 Noble Capital Gevo price target raised to $5 from $3.50 at Noble Capital 02/06/20 Noble Capital Gevo initiated with an Outperform at Noble Capital CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 07:56 Today Needham Ceragon Networks double-downgraded to Underperform from Buy at Needham 07:17 Today Needham Ceragon Networks downgraded to Underperform from Buy at Needham 05/04/20 Needham Ceragon longer-term news continues to improve, says Needham 04/17/20 Needham Ceragon Networks upgraded to Buy from Hold at Needham CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 09/22/20 Guggenheim Guggenheim taking more conservative view, downgrades CytomX to Neutral 09/22/20 Guggenheim CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim 09/15/20 Citi CytomX Therapeutics price target lowered to $8.50 from $11 at Citi 06/01/20 Jefferies Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold APM Aptorum Group $3.17 / -0.11 (-3.35%) 07/13/20 Alliance Global Partners Aptorum Group initiated with a Buy at Alliance Global Partners PG MS NFLX USB GEVO CRNT CTMX PG Procter & Gamble $133.56 / -1.275 (-0.95%) 07:08 Today Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 07:03 Today Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open MS Morgan Stanley $74.99 / -0.23 (-0.31%) 07:35 Today Morgan Stanley reports Q4 EPS $1.81, consensus $1.27 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 06:46 Today U.S. Bancorp reports Q4 EPS 95c, consensus 95c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/14/20 U.S. Bancorp reports Q3 diluted EPS 99c, consensus 91c GEVO Gevo $11.01 / +4.62 (+72.30%) 08/28/20 Gevo says Peak Value IP sets IP portfolio at greater than $400M CRNT Ceragon Networks $6.45 / +1.6 (+32.99%) 11/02/20 Ceragon Networks reports Q3 EPS 3c, consensus (1c) 08/03/20 Ceragon Networks reports Q2 EPS (6c), consensus (7c) CTMX CytomX Therapeutics $8.48 / +0.55 (+6.94%) 11/05/20 CytomX Therapeutics reports Q3 EPS (32c), consensus (48c) 21 Jan PG MS NFLX USB PG Procter & Gamble $133.56 / -1.275 (-0.95%) 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports 10/13/20 P&G investors approve proposal for deforestation report, Bloomberg says MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/05/21 Oatly planning 2021 initial public offering, CNBC reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 12/22/20 'James Bond' studio MGM Holdings exploring sale, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 11/25/20 Bank of America rumors of flat bonus pool rattles traders, Bloomberg says 09/29/20 Citi's McGuire meets with banking leaders over likely NYC mayoral run, CNBC says 09/17/20 Fed mulls extension of bank dividend restrictions, Bloomberg says PG MS NFLX USB GEVO APM PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday MS Morgan Stanley $74.99 / -0.23 (-0.31%) 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 10/15/20 Fly Intel: Wall Street's top stories for Thursday 10/15/20 Fly Intel: Wall Street's top stories at midday 10/15/20 Fly Intel: Pre-market Movers NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/14/20 Fly Intel: Pre-market Movers 10/01/20 Fly Intel: Wall Street's top stories for Thursday 10/01/20 Fly Intel: Wall Street's top stories at midday GEVO Gevo $11.01 / +4.62 (+72.30%) 01/19/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Pre-market Movers APM Aptorum Group $3.17 / -0.11 (-3.35%) 09/29/20 Fly Intel: Wall Street's top stories for Tuesday 09/29/20 Fly Intel: Wall Street's top stories at midday 09/29/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum 03/15/21 33rd Annual Roth Virtual Conference 08:30 Today Morgan Stanley - MS 08:30 Today Procter & Gamble - PG 09:00 Today U.S. Bancorp - USB 02/08/21 Ceragon Networks - CRNT 01/25/21 U.S. Bancorp PG MS NFLX USB PG Procter & Gamble $133.56 / -1.275 (-0.95%) 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/15/21 Unusual call flow in option market yesterday 01/14/21 $1.3M call seller in Morgan Stanley opens two week position into earnings 01/12/21 Unusual call flow in option market yesterday 01/11/21 Diagonal call spread in Morgan Stanley rolls $16M premium position NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/04/21 US Bancorp put volume heavy and directionally bearish 12/02/20 US Bancorp put volume heavy and directionally bearish 09/14/20 US Bancorp call volume above normal and directionally bullish

Recommendations	Comerica price target raised to $67 from $56 at Truist » 08:59 01/20/21 01/20 08:59 01/20/21 08:59 CMA Comerica $63.85 / +0.16 (+0.25%) Truist analyst Jennifer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options CMA Comerica $63.85 / +0.16 (+0.25%) 08/19/20 Comerica partners with Minority Depository Institutions 07/21/20 Comerica up 4.8% after reporting Q2 results CMA Comerica $63.85 / +0.16 (+0.25%) 07:57 Today B. Riley Securities Comerica price target raised to $72 from $65 at B. Riley Securities 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/14/21 Raymond James Comerica upgraded to Outperform from Market Perform at Raymond James 01/13/21 Baird Comerica downgraded to Neutral following rally at Baird CMA Comerica $63.85 / +0.16 (+0.25%) 01/19/21 Comerica reports Q4 EPS $1.49, consensus $1.19 10/20/20 Comerica reports Q3 EPS $1.44, consensus 83c 07/21/20 Comerica reports Q2 EPS 80c, consensus 21c 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 04/20/21 Comerica - CMA CMA Comerica $63.85 / +0.16 (+0.25%) 10/20/20 Early notable gainers among liquid option names on October 20th
Initiation	Array Technologies initiated with an Accumulate at Johnson Rice » 08:58 01/20/21 01/20 08:58 01/20/21 08:58 ARRY Array Technologies $48.36 / +2.36 (+5.13%) Johnson Rice initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Options ARRY Array Technologies $48.36 / +2.36 (+5.13%) 11/30/20 Array Technologies announces 1GW purchase agreement with RP Construction ARRY Array Technologies $48.36 / +2.36 (+5.13%) 08:43 Today Credit Suisse Array Technologies price target raised to $42 from $37 at Credit Suisse 01/07/21 Piper Sandler Array Technologies initiated with an Overweight at Piper Sandler 01/04/21 Goldman Sachs Array Technologies price target raised to $52 from $50 at Goldman Sachs 12/22/20 GLJ Research GLJ sees 'more bad news than good' from solar tax credit extension 03 Dec 15 Oct ARRY Array Technologies $48.36 / +2.36 (+5.13%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/30/20 Fly Intel: After-Hours Movers ARRY Array Technologies $48.36 / +2.36 (+5.13%) 11/02/20 Nine new option listings and four option delistings on November 2nd
Recommendations	Seagate price target raised to $56 from $47 at Wedbush » 08:58 01/20/21 01/20 08:58 01/20/21 08:58 STX Seagate $61.20 / +0.74 (+1.22%) Wedbush analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options STX Seagate $61.20 / +0.74 (+1.22%) 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products 11/05/20 Climb Channel Solutions adds Seagate data storage systems to distribution line STX Seagate $61.20 / +0.74 (+1.22%) 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital 12/31/20 KeyBanc Industry data points to flat monthly contract pricing for DRAM, says KeyBanc 12/28/20 Mizuho Seagate price target raised to $65 from $54 at Mizuho STX Seagate $61.20 / +0.74 (+1.22%) 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c 10/22/20 Notable companies reporting after market close 10/22/20 Fly Intel: What to watch in data storage earnings reports STX Seagate $61.20 / +0.74 (+1.22%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers 01/21/21 Seagate - STX STX Seagate $61.20 / +0.74 (+1.22%) 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish 10/22/20 Seagate put volume heavy and directionally bearish
Recommendations	Exponent price target raised to $105 from $81 at Truist » 08:56 01/20/21 01/20 08:56 01/20/21 08:56 EXPO Exponent $95.42 / +1.27 (+1.35%) Truist analyst Tobey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events EXPO Exponent $95.42 / +1.27 (+1.35%) 05/13/20 Sidoti Exponent upgraded to Buy from Neutral at Sidoti 04/09/20 Sidoti Exponent downgraded to Neutral from Buy at Sidoti 03/19/20 Sidoti Exponent upgraded to Buy from Neutral at Sidoti 03/19/20 Sidoti Exponent upgraded to Buy from Neutral at Sidoti EXPO Exponent $95.42 / +1.27 (+1.35%) 10/29/20 Exponent sees Q4 revenue down 12%-15% amid COVID headwinds 10/29/20 Exponent reports Q3 EPS 34c, consensus 31c 10/29/20 Exponent reports Q3 EPS 34c, consensus 31c 07/30/20 Exponent reports Q2 EPS 31, consensus 25c 02/04/21 Exponent - EXPO
Hot Stocks	Morgan Stanley expects net new assets to remain above historical levels 08:56 01/20/21 01/20 08:56 01/20/21 08:56 MS Morgan Stanley $74.99 / -0.23 (-0.31%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MS Morgan Stanley $74.99 / -0.23 (-0.31%) 08:55 Today Morgan Stanley doesn't see any change to policy rates in the near-term 08:45 Today Morgan Stanley: LT goal is for wealth management to generate margin of over 30% 08:44 Today Morgan Stanley CEO: 2021 to be a transition year 08:42 Today Morgan Stanley expects to close Eaton Vance deal no later than early in Q2 MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/11/21 Piper Sandler Morgan Stanley price target raised to $76 from $54 at Piper Sandler 01/06/21 Deutsche Bank Morgan Stanley price target raised to $68 from $53 at Deutsche Bank 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Barclays Morgan Stanley upgraded to Overweight with $88 target at Barclays MS Morgan Stanley $74.99 / -0.23 (-0.31%) 07:35 Today Morgan Stanley reports Q4 EPS $1.81, consensus $1.27 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/05/21 Oatly planning 2021 initial public offering, CNBC reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 12/22/20 'James Bond' studio MGM Holdings exploring sale, WSJ reports MS Morgan Stanley $74.99 / -0.23 (-0.31%) 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 10/15/20 Fly Intel: Wall Street's top stories for Thursday 10/15/20 Fly Intel: Wall Street's top stories at midday 10/15/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum 08:30 Today Morgan Stanley - MS MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/15/21 Unusual call flow in option market yesterday 01/14/21 $1.3M call seller in Morgan Stanley opens two week position into earnings 01/12/21 Unusual call flow in option market yesterday 01/11/21 Diagonal call spread in Morgan Stanley rolls $16M premium position

Events

Earnings calls, analyst events, roadshows and more

PNFP
Today at 09:30

Pinnacle Financial - PNFP Conference Calls
NJR
Today at 09:30

New Jersey Resources Corp Firm Sponsored Meetings
Today at 10:00

Housing Market Index: January 2021 Government Event
BOKF
Today at 10:00

BOK Financial - BOKF Conference Calls
FAST
Today at 10:00

Fastenal - FAST Conference Calls
FULT
Today at 10:00

Fulton Financial - FULT Conference Calls
SMBK
Today at 10:00

SmartFinancial - SMBK Conference Calls
AG
Today at 10:00

First Majestic - AG Conference Calls
PURE
Today at 10:00

PURE Bioscience, Inc. Firm Sponsored Meetings
SHLS
Today at 10:15

Shoals Technologies - SHLS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

NYSE market internals summary

TODAY'S FREE FLY STORIES

Get Full Fly Access